MINI FUTURE LONG - EUROAPI Share Price

DE000MG373W4

Real-time Bid/Ask 14:53:33 07/06/2024 BST
1.33 ^EUR / 1.35 ^EUR	-33.66%

Current month	+22.42%
1 month	+102.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart EUROAPI

Latest news about EUROAPI

EuroAPI appoints mediator to help restructure pile of debt, shares drop	08:43am	RE
Euroapi: ad hoc mandate for the financing of Focus-27	06:27am	CF
Market update : FOCUS-27 transformation project financing	06-06	GL
Euroapi to Secure EU Funding for Pharmaceutical Programs	06-06	MT

More news

Quotes 5-day view

Date	Price	Change
07/06/24	1.3	-35.64%
06/06/24	2.02	+9.19%
05/06/24	1.85	+6.94%
04/06/24	1.73	-2.26%
03/06/24	1.77	+7.27%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 01:54 pm

More quotes

Static data

Product type	Knock-Out with Stop Loss
Buy / Sell	CALL
Underlying	EUROAPI
Issuer	Morgan Stanley
WKN	MG373W
ISIN	DE000MG373W4
Date issued	29/04/2024
Strike	1.921 €
Maturity	Unlimited
Parity	1 : 1
Emission price	0.72 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	2.02 €
Lowest since issue	0.87 €
Spread	0.02 €
Spread %	1.47%

Company Profile

EUROAPI specializes in the development and manufacture of active pharmaceutical ingredients on behalf of healthcare industries. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. EUROAPI has 6 production sites located in France (2), the United Kingdom, Germany, Italy and Hungary.

Sector

More about the company

Ratings for EUROAPI

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: EUROAPI

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

3.88 EUR

Average target price

3.52 EUR

Spread / Average Target

-9.28%

Consensus